The Dexcom G6 continuous glucose monitoring (CGM) system allows you to always know your glucose numbers with just a quick glance at your smart device* or receiver. It also allows you to share your data with up to 10 followers with the Dexcom Follow app,† and best of all — it integrates with the t:slim X2 insulin pump with Control-IQ technology.
* Smart devices sold separately
Why Choose the Dexcom G6?
Pairing the t:slim X2 insulin pump with Control-IQ technology and the Dexcom G6 CGM System work together to improve time in range1 and requires zero fingersticks for calibration or mealtime dosing.‡
- Share your glucose data with up to 10 followers†
- See glucose data in real time on your compatible smart devices*
- Customize your settings and get notified when you're heading high or low
- Ask Siri to read your glucose numbers and display your graph on the lock screen with the Dexcom Follow app§
Hear how Dakota O., Dexcom Warrior and 15 years #T1DStrong, has seen a great improvement in his time-in-range and the ease of managing his diabetes.
Brief Safety Statement
Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood
glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of
acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
Responsible Use of Control-IQ Technology
Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, patients are still responsible for actively managing their diabetes. Control-IQ technology does not prevent
all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires that patients accurately input information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as
intended unless all system components, including CGM, infusion sets and pump cartridges, are used as instructed. Importantly, the system cannot adjust insulin dosing if the pump is not receiving CGM readings. Since there are situations and emergencies
that the system may not be capable of identifying or addressing, patients should always pay attention to their symptoms and treat accordingly.
* Smart devices sold separately. For a list of compatible smart devices, visit www.dexcom.com/compatibility.
† Following your shared data requires the Dexcom Follow app. Internet
connectivity required for data sharing. Followers should always confirm readings on the Dexcom G6 app or receiver (t:slim X2 pump) before making treatment decisions.
‡ If your glucose alerts and readings from the Dexcom G6 CGM do not match
symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
§ iOS devices only.
References:
1. Brown SA, Kovatchev BP, Raghinaru D, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019;381(18):1707-17.
Important Safety Information
RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with U-100 insulin only.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates,
for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm
commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: technology is intended for use with a compatible integrated continuous glucose
monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted
to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.
Warning: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
